Device Trial Radar · NCT02255851
Sentinel(TM) Post-Market Registry
Last checked: Nov 20, 2026Latest source record: May 23, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Claret MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 3, 2014
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The SENTINEL Post-Market Registry is a prospective, multi-center, registry using the CE-Marked Sentinel System in subjects with severe symptomatic calcified native aortic valve stenosis indicated for TAVR. Subjects enrolled in the registry will undergo TAVR + Sentinel. Basic demographic information and detailed procedural data will be captured and documented in a registry case report form. All Sentinel filters will be sent for histopathology at an independent core-lab.
Conditions
- Transcatheter Aortic Valve Replacement
- Severe Symptomatic Calcified Native Aortic Valve Stenosis
Interventions
SENTINEL (Cerebral Protection System)Device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Observational EndpointTime frame: Post-Procedure (day 1)
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.